Transcode Therapeutics Inc
RNAZ
$1.76+0.00%
End of day · as of Sep 21, 2026, 9:52 PM ET
Mkt cap
$5.08M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-28.14
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Use this RNAZ research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RNAZ income, balance, and cash tables.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company in the Healthcare sector.
Latest cached Transcode Therapeutics Inc (RNAZ) net income for FY2025 was -$34.7M. Statements: https://lician.com/financials/rnaz
Transcode Therapeutics Inc (RNAZ) market capitalization is $5.1M on the latest cached snapshot.
Transcode Therapeutics Inc (RNAZ) cached previous close $1.76; day range $1.67 – $1.97; volume 65,370. Session quote: https://lician.com/quote/rnaz
Transcode Therapeutics Inc (RNAZ) latest cached earnings event is "RNAZ earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RNAZ filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/rnaz